Zelboraf, skin cancer medicine, has gotten approval from European Drug Regulators
Roche has announced, on Monday, that the European Drug Regulators have approved the company’s new skin cancer medicine, i.e. Zelboraf
Read moreRoche has announced, on Monday, that the European Drug Regulators have approved the company’s new skin cancer medicine, i.e. Zelboraf
Read more